World Journal of
Pharmaceutical and Life Sciences

TO EVALUATE THE EFFICACY OF SINGLE DRUG THERAPY OVER POLYCYSTIC OVARIAN SYNDROME.

Dr. Anu Koul*, Dr. Tanuja Manoj Nesari, Dr. Kiran Jadhav

ABSTRACT

Polycystic ovary syndrome (PCOS) affects 20-25% of women of reproductive age and up to 30% in some high-risk groups. PCOS leads to irregularity in the menstrual cycle and the appearance of superfluous male hormones (androgens/testosterones). Menstrual cycles might be regular prior but subsequently turn out irregular, or the incipience of menses may be delayed. Women may experience infertility by meagreness of ovulation in the menstruation cycle resulting out for difficulty in conceiving. Ayurvedic single drug therapy has been emerging in addition to established medical and surgical medication for PCOS. PCOS is a disorder involving Pitta, Kapha, Medas, Ambhuvahasrotas & Artava Dhatu The causes of PCOS as per Ayurveda can be taken as eating excessive sweet and kaphagenic foods, mandagni because of this is kapha getting aggravated in PCOS, we find kapha disorder. In present case study, we have studied safety and effectiveness of exclusive single drug therapy with use of reserve wellness wrapping technique in PCOS patients. Study eventuate reveal that majority of hormonal level significantly changed post-medication compared to pre-medication. Study results shown that there was statistically significant improvement in Luteinizing Hormone (LH), Prolactin, AMH, Fasting Insulin, SGPT, post medication from the preoperative values (P<0.05). LH/FSH Ratio at pre-medicationwas2.82:1, which was reduced to 1.01:1 at post medication (p<0.001). No adverse event was reported during conduct of present study.

[Full Text Article]   [Download Certificate]